Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Centrally active and orally bioavailable antidotes for organophosphate exposure and methods for making and using them

Centrally active and orally bioavailable antidotes for organophosphate exposure and methods for making and using them

US Patent 10800749 · Granted Oct 13, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Sulfur (VI) fluoride compounds and methods for the preparation thereof2025
Centrally active and orally bioavailable uncharged bisoxime antidotes for organo2023
Centrally active and orally bioavailable uncharged bisoxime antidotes for organo2023
Arylfluorosulfate compounds and methods2023
Thionyl tetrafluoride modified compounds and uses2022
Centrally active and orally bioavailable antidotes for organophosphate exposure 2021
Centrally active and orally bioavailable antidotes for organophosphate exposure 2021
Centrally active and orally bioavailable antidotes for organophosphate exposure 2021
Centrally active and orally bioavailable antidotes for organophosphate exposure 2021
Sulfur(VI) fluoride compounds and methods for the preparation thereof2020
Polymerization of silyl- and fluoro-containing monomers2020
Selective alpha-7 nicotinic receptor agonists and methods for making and using t2019